DEA schedule

Is mirabegron a controlled substance?

Federal schedule for mirabegron from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

No. Mirabegron is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and mirabegron is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted mirabegron?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Mirabegron
SourceWhat it lists
FDA NDC directory21 prescription listings from 9 labelers, none with a DEA schedule
DEA controlled substances listmirabegron is not on the list

Mirabegron NDC listings

NDC listings for Mirabegron
NDCProductFormStrengthLabelerDEA schedule
0469-5020Myrbetriqgranule, for suspension, extended release8 mg/mLAstellas Pharma US, Inc.None
0469-2601Myrbetriqtablet, film coated, extended release25 mg/1Astellas Pharma US, Inc.None
0469-2602Myrbetriqtablet, film coated, extended release50 mg/1Astellas Pharma US, Inc.None
67877-890Mirabegronfor suspension, extended release8 mg/mLAscend Laboratories, LLCNone
70518-4631Mirabegrontablet, extended release25 mg/1REMEDYREPACK INC.None
70710-1159Mirabegrontablet, extended release25 mg/1Zydus Pharmaceuticals (USA) Inc.None
70771-1752Mirabegrontablet, extended release25 mg/1Zydus Lifesciences LimitedNone
70518-4304Mirabegrontablet, extended release50 mg/1REMEDYREPACK INC.None
70710-1160Mirabegrontablet, extended release50 mg/1Zydus Pharmaceuticals (USA) Inc.None
70771-1753Mirabegrontablet, extended release50 mg/1Zydus Lifesciences LimitedNone
67184-0571Mirabegrontablet, film coated, extended release25 mg/1Qilu Pharmaceutical Co., Ltd.None
68180-151MIRABEGRONtablet, film coated, extended release25 mg/1Lupin Pharmaceuticals, Inc.None
69238-2860Mirabegrontablet, film coated, extended release25 mg/1Amneal Pharmaceuticals NY LLCNone
71335-2807MIRABEGRONtablet, film coated, extended release25 mg/1Bryant Ranch PrepackNone
71335-2809MIRABEGRONtablet, film coated, extended release25 mg/1Bryant Ranch PrepackNone
68180-152MIRABEGRONtablet, film coated, extended release50 mg/1Lupin Pharmaceuticals, Inc.None
69238-2861Mirabegrontablet, film coated, extended release50 mg/1Amneal Pharmaceuticals NY LLCNone
70518-4665MIRABEGRONtablet, film coated, extended release50 mg/1REMEDYREPACK INC.None
71335-2808MIRABEGRONtablet, film coated, extended release50 mg/1Bryant Ranch PrepackNone
71335-2810MIRABEGRONtablet, film coated, extended release50 mg/1Bryant Ranch PrepackNone
67184-0572Mirabgeorntablet, film coated, extended release50 mg/1Qilu Pharmaceutical Co., Ltd.None

Questions

Is mirabegron a controlled substance?

No. Mirabegron is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and mirabegron is not on the DEA controlled substances list.

Is mirabegron a narcotic?

No. Mirabegron is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is beta3-Adrenergic Agonist.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.

More on Mirabegron

Try it on your own data today.

Free to start. Most teams are using it the same day.

Get started for freeSee pricing